Press

IMAX Corporation Reports First-Quarter 2018 Results
May 1, 2018

NEW YORK, May 1, 2018 /PRNewswire/ --

IMAX Logo. (PRNewsFoto/IMAX Corporation)

HIGHLIGHTS

  • Delivered Q1 2018 net income and adjusted net income of $8.5 million and $13.4 million, respectively, compared to Q1 2017 net income and adjusted net income of $0.1 million and $3.9 million, respectively.
  • Achieved Q1 2018 earnings per share and adjusted earnings per share of $0.13 and $0.21, respectively compared to $nil and $0.06, respectively in Q1 2017.
  • Adjusted EBITDA per Credit Facility was $31.4 million, up 70% compared to the same period last year.
  • Gross Profit of $50.7 million, resulted in gross margins of 60%, a 750-basis point increase versus Q1 2017.
  • Global IMAX box office of $246.9 million helped drive total revenues to $85.0 million, up 24% from the prior year period.
  • Repurchased $13.4 million of shares at an average price of $20.46 per share.
  • Successfully launched IMAX with Laser, the Company's next-generation laser experience, bolstered by over 150 signings to date.
  • Avengers: Infinity War, the first commercial film shot entirely with IMAX cameras, kicked off the summer blockbuster season, delivering a record $41.5 million in opening weekend IMAX box office.

IMAX Corporation (NYSE: IMAX) today reported first-quarter 2018 revenues of $85.0 million, gross profit of $50.7 million and net income attributable to common shareholders of $8.5 million, which calculates to $0.13 per diluted share. Adjusted net income attributable to common shareholders for the first quarter was $13.4 million, which calculates to $0.21 per diluted share. Adjusted EBITDA per Credit Facility was $31.4 million. For reconciliations of reported results to non-GAAP financial results, and for the definition and reconciliation of Adjusted EBITDA per Credit Facility, please see the end of this press release.

"Our first quarter results were strong from both a financial and strategic standpoint. We modified our programming strategy, demonstrated operating leverage and set the table for the successful launch of IMAX with Laser, which was bolstered by over 150 signings to date," said Richard L. Gelfond, IMAX CEO. "In addition to benefitting from the revenue and cost initiatives we implemented last year—which helped drive Adjusted EBITDA growth of 70%, compared to Q1 last year—our recent performance also reflects IMAX's growing value proposition to content-creators and moviegoers alike. As content-creators emphasize blockbuster-type content and as consumers seek differentiated moviegoing experiences, The IMAX Experience® is becoming an increasingly important platform to launch and experience global franchise content." Gelfond concluded, "We believe our global footprint, coupled with our focus on creating differentiated experiences for the biggest cinematic releases, uniquely positions IMAX to benefit from these trends."

First-Quarter 2018 Results

Network Update
During the quarter, the Company installed 16 theater systems, all of which were for new theater locations. The total IMAX® theater network consisted of 1,382 systems as of March 31, 2018, of which 1,286 were in commercial multiplexes. There were 529 theaters in backlog as of March 31, 2018, compared to the 524 in backlog as of March 31, 2017.

IMAX signed contracts for 45 new theaters across 8 countries in the first quarter of 2018.  For a breakdown of theater system signings, installations, network and backlog by type for the first quarter of 2018, please see the end of this press release.

Box Office Update
Gross box office from IMAX DMR® films increased 16.4% to $246.9 million in the first quarter of 2018 from $212.1 million in the first quarter of 2017. Gross box office was generated primarily by the exhibition of 22 films (14 new and 8 carryovers), as compared to 18 films (12 new and 6 carryovers) exhibited in the first quarter of 2017.

First-Quarter Consolidated Results
The gross margin across all segments in the first quarter of 2018 was $50.7 million, or 59.6% of total revenues, compared to $35.8 million, or 52.1% of total revenues, in the first quarter of 2017. Operating expenses (which includes SG&A, excluding stock-based compensation, plus R&D) were $27.3 million in the quarter, down 9% compared to $30.0 million in the first quarter of 2017.

"Looking ahead, our objectives this year are focused on improving the earnings power of our core business, increasing the differentiation of The IMAX Experience relative to other moviegoing options, and reinforcing the strength of our brand amongst worldwide consumers." Gelfond continued, "We believe these initiatives, coupled with our continued signings and installation momentum, should create meaningful value across the IMAX ecosystem. Moreover, we're encouraged by the exciting upcoming film slate, the successful launch of IMAX with Laser and our continued focus on controlling costs."

FASB ASC Topic 606 Revenue Recognition
As a result of adopting ASC Topic 606 regarding changes to revenue recognition, the Company recognized an additional $0.7 million of net incremental revenue in the first quarter of 2018. Additional details related to these revenue recognition changes can be found in our 10-Q document.

First-Quarter Segment Results

Network Business

  • Network business revenues were $44.9 million in the quarter, compared with $39.3 million in the prior-year period. Gross margin for the network business were 70.2% in the most recent quarter, compared to 72.2% in the prior-year period.
  • IMAX DMR revenues were $27.1 million in the first quarter of 2018, compared to $23.4 million in the first quarter of 2017. Gross margin for the IMAX DMR segment was 69.4%, compared to 74.6% in the prior-year comparative period. The lower margins in the recent quarter reflect increased marketing costs versus last year.
  • Revenue from joint revenue-sharing arrangements were $17.9 million in the quarter, compared with $15.2 million in the prior-year period.  Gross margin for joint revenue-sharing arrangements was 71.3%, compared to 67.3% in the prior-year comparative period.

Theater Business

  • Theater business segment revenues were $35.0 million in the quarter, compared with $23.2 million in the prior-year comparative period, primarily reflecting the installation of 7 additional sales-type theaters.
  • Gross margin on sales and sales-type leases was 64.0% compared with 46.4% in the year-ago period. The increase in the recent period is primarily the result of higher average margin per new system and no upgraded systems in the first quarter of 2018 versus 1 upgrade in 2017.

Supplemental Materials
For more information about the Company's results, please refer to the IMAX Investor Relations website located at investors.imax.com.

Investor Relations Website and Social Media
On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at www.imax.com/content/investor-relations. The Company expects to provide such updates on Friday of each week, although the Company may change this timing without notice. Results will be displayed with a one-week lag. In addition, the Company maintains a Twitter account: @IMAX_Investors. The Company intends to use Twitter to disclose the box office information, as well as other information that may be of interest to the Company's investor community.

The information posted on the Company's website and/or via its Twitter account may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website and its Twitter account in addition to the Company's press releases, SEC filings and public conference calls and webcasts.

Conference Call
The Company will host a conference call today at 8:30AM ET to discuss its first quarter and 2018 financial results. This call is being webcast by Nasdaq and can be accessed at investors.imax.com. To access the call via telephone, interested parties in the US and Canada should dial (800) 289-0438 approximately 5 to 10 minutes before the call begins. Other international callers should dial (647) 484-0478. The conference ID for the call is 9118022. A replay of the call will be available via webcast at investors.imax.com or via telephone by dialing (888) 203-1112 (US and Canada), or (647) 436-0148 (international). The Conference ID for the telephone replay is 9118022.

About IMAX Corporation
IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX theaters to connect with audiences in extraordinary ways, and, as such, IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of March 31, 2018, there were 1,382 IMAX theater systems (1,286 commercial multiplexes, 12 commercial destinations, 84 institutional) operating in 77 countries. On Oct. 8, 2015, shares of IMAX China, a subsidiary of IMAX Corp., began trading on the Hong Kong Stock Exchange under the stock code "HK.1970."

IMAX®, IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience®, IMAX Is Believing® and IMAX nXos® are trademarks of IMAX Corporation. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

This press release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, references to future capital expenditures (including the amount and nature thereof), business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, plans and references to the future success of IMAX Corporation together with its consolidated subsidiaries (the "Company") and expectations regarding the Company's future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company's growth and operations in China; the performance of IMAX DMR films; the signing of theater system agreements; conditions, changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates; competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks relating to recent consolidation among commercial exhibitors and studios; risks related to new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security; risks related to the Company's inability to protect the Company's intellectual property; general economic, market or business conditions; the failure to convert theater system backlog into revenue; changes in laws or regulations; the failure to fully realize the projected cost savings and benefits from the Company's restructuring initiative; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

For additional information please contact:

Investors:

Michael K. Mougias, New York

212-821-0187

mmougias@imax.com


Business Media:

Sloane & Company, New York

Whit Clay

212-446-1864

wclay@sloanepr.com

Media:

IMAX Corporation, New York

Adam Davis

212-821-0116

adavis@imax.com


Entertainment Media:

Principal Communications Group, Los Angeles

Melissa Zuckerman/Paul Pflug

323-658-1555

melissa@pcommgroup.com

paul@pcommgroup.com

 

Additional Information

Signings and Installations






March 31, 2018








Three Months

Ended March 31,




Theater Signings:

2018


2017




Full new sales and sales-type lease arrangements

15


36




New traditional joint revenue sharing arrangements

22


-




New hybrid joint revenue sharing lease arrangements

8


2




Total new theaters

45


38




Upgrades of IMAX theater systems

-


1




Total Theater Signings

45


39



















Three Months

Ended March 31,




Theater Installations:

2018


2017




Full new sales and sales-type lease arrangements

13


5




New traditional joint revenue sharing arrangements

3


8




New hybrid joint revenue sharing lease arrangements

-


1




Total new theaters

16


14




Upgrades of IMAX theater systems

-


1

(1)



Total Theater Installations

16


15












Three Months

Ended March 31,








Theater Backlogs:

2018


2017




New sales and sales-type lease arrangements

178

(2)

176




New joint revenue sharing arrangements







Hybrid lease arrangements

116


93




Traditional arrangements

235


255




Total Theater Backlog

529

(3)

524

(4)











Three Months

Ended March 31,








Theater Network:

2018


2017




Commercial Multiplex Theaters:







Sales and sales-type lease arrangements

568


472




Traditional joint revenue sharing arrangements

610


533




Hybrid joint revenue sharing lease arrangements

108


116




Total Commercial Multiplex Theaters

1,286


1,121











Commercial Destination Theaters

12


14




Institutional Theaters

84


91




Total Theater Network

1,382


1,226



____________________






(1)

Includes one installation of an upgrade to a laser-based digital system under a sales arrangement.

(2)

Includes 14 theater systems which were previously classified under joint revenue sharing arrangements – hybrid sales arrangements.

(3)

Includes 33 laser-based digital theater system configurations, including five upgrades.

(4)

Includes 21 laser-based digital theater system configurations, including three upgrades.

 

 

IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands of U.S. dollars, except per share amounts)

(Unaudited)












Three Months Ended




March 31,




2018


2017

Revenues







Equipment and product sales


$

19,513


$

11,544

Services



44,746



38,844

Rentals



18,202



15,857

Finance income



2,523



2,412





84,984



68,657

Costs and expenses applicable to revenues







Equipment and product sales



7,972



7,464

Services



20,351



19,814

Rentals



5,969



5,608





34,292



32,886

Gross margin



50,692



35,771

Selling, general and administrative expenses



28,083



30,941


(including share-based compensation expense of $4.4 million for the three months ended March 31, 2018 (2017
— $5.3 million))






Research and development



3,592



4,334

Amortization of intangibles



892



602

Receivable provisions, net of recoveries



451



185

Exit costs, restructuring charges and associated impairments



702



-

Income (loss) from operations



16,972



(291)

Interest income



247



228

Interest expense



(494)



(455)

Income (loss) from operations before income taxes



16,725



(518)

Provision for income taxes



(4,453)



(114)

Loss from equity-accounted investments, net of tax



(205)



(255)

Net income (loss)



12,067



(887)

Less: net (income) loss attributable to non-controlling interests



(3,562)



962

Net income attributable to common shareholders


$

8,505


$

75









Net income per share attributable to common shareholders - basic and diluted:




Net income per share — basic and diluted


$

0.13


$

-









Weighted average number of shares outstanding (000's):








Basic



64,555



66,363


Fully Diluted



64,619



67,180









Additional Disclosure:







Depreciation and amortization(1)


$

13,521


$

12,088









(1) Includes $0.1 million of amortization of deferred financing costs charged to interest expense for the three months ended March 31, 2018 (2017 -
$0.1 million).

 

 

IMAX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands of U.S. dollars)

(Unaudited)


















March 31,


December 31,


2018


2017






Assets






Cash and cash equivalents

$

145,579


$

158,725

Accounts receivable, net of allowance for doubtful accounts of $2,075 (December 31, 2017 — $1,613)


119,754



130,546

Financing receivables


129,774



129,494

Inventories


29,096



30,788

Prepaid expenses


10,165



7,549

Film assets


7,714



5,026

Property, plant and equipment


278,978



276,781

Other assets


62,569



26,757

Deferred income taxes


25,145



30,708

Other intangible assets


30,533



31,211

Goodwill


39,027



39,027

Total assets

$

878,334


$

866,612







Liabilities






Bank indebtedness

$

24,867


$

25,357

Accounts payable


13,782



24,235

Accrued and other liabilities


94,023



100,140

Deferred revenue


112,131



113,270

Total liabilities


244,803



263,002







Commitments and contingencies












Non-controlling interests


5,471



1,353







Shareholders' equity






Capital stock common shares — no par value. Authorized — unlimited number.






64,287,977 issued and 63,996,413 outstanding (December 31, 2017 — 64,902,201 issued and
64,695,550 outstanding)


441,303



445,797

Less: Treasury stock, 291,564 shares at cost (December 31, 2017 — 206,651)


(5,992)



(5,133)

Other equity


173,866



175,300

Accumulated deficit


(60,418)



(87,592)

Accumulated other comprehensive loss


(138)



(626)

Total shareholders' equity attributable to common shareholders


548,621



527,746

Non-controlling interests


79,439



74,511

Total shareholders' equity


628,060



602,257

Total liabilities and shareholders' equity

$

878,334


$

866,612

 

 

IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands of U.S. dollars)

(Unaudited)



Three Months Ended March 31,




2018


2017









Cash provided by (used in):







Operating Activities








Net income (loss)


$

12,067


$

(887)


Adjustments to reconcile net income to cash from operations:








Depreciation and amortization



13,521



12,088


Write-downs, net of recoveries



1,036



4,010


Change in deferred income taxes



(465)



(958)


Stock and other non-cash compensation



5,141



5,660


Unrealized foreign currency exchange loss (gain)



35



(171)


Loss from equity-accounted investments



106



156


Loss on non-cash contribution to equity-accounted investees



99



99


Investment in film assets



(6,259)



(3,334)


Changes in other non-cash operating assets and liabilities



(9,818)



(17,280)


Net cash provided by (used in) operating activities



15,463



(617)










Investing Activities








Purchase of property, plant and equipment



(6,588)



(4,068)


Investment in joint revenue sharing equipment



(4,810)



(7,547)


Acquisition of other intangible assets



(555)



(1,591)


Investment in new business ventures



-



(1,000)


Net cash used in investing activities



(11,953)



(14,206)










Financing Activities








Increase in bank indebtedness



-



-


Repayment of bank indebtedness



(500)



(500)


Repurchase of common shares



(13,396)



-


Treasury stock purchased for future settlement of restricted share units



(5,992)



(779)


Taxes withheld and paid on employee stock awards vested



(1,028)



(146)


Settlement of restricted share units and options



(173)



(11,158)


Issuance of subsidiary shares to a non-controlling interest



4,449



-


Common shares issued - stock options exercised



-



13,082


Net cash (used in) provided by financing activities



(16,640)



499










Effects of exchange rate changes on cash



(16)



46










Decrease in cash and cash equivalents during period



(13,146)



(14,278)










Cash and cash equivalents, beginning of period



158,725



204,759










Cash and cash equivalents, end of period


$

145,579


$

190,481


 

 

IMAX CORPORATION
SELECTED FINANCIAL DATA
In accordance with United States Generally Accepted Accounting Principles
(in thousands of U.S. dollars)


The Company has four primary reporting groups identified by nature of product sold or service provided: (1) Network Business, representing variable revenue generated by box-office results and which includes the reportable segments of IMAX DMR and contingent rent from the JRSAs and IMAX systems segments; (2) Theater Business, representing revenue generated by the sale and installation of theater systems and maintenance services, primarily related to the IMAX Systems and Theater System Maintenance reportable segments, and also includes fixed hybrid revenues and upfront installation costs from the JRSA segment; (3) New Business, which includes content licensing and distribution fees associated with our original content investments, virtual reality initiatives, IMAX Home Entertainment, and other business initiatives that are in the development and/or start-up phase, and (4) Other; which includes the film post-production and distribution segments and certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items.







Three Months






Ended March 31,






2018


2017

Revenue








Network Business









IMAX DMR



$

27,051


$

23,408


Joint revenue sharing arrangements – contingent rent




17,861



15,233


IMAX systems – contingent rent




-



688







44,912



39,329

Theater Business








IMAX systems










Sales and sales-type leases




18,138



6,942



Ongoing fees and finance income




2,730



2,585


Joint revenue sharing arrangements – fixed fees




-



470


Theater system maintenance




12,712



11,045


Other theater




1,377



2,165







34,957



23,207

New Business




608



1,280











Other









Film distribution and post-production




3,734



3,584


Other




773



1,257







4,507



4,841

Total



$

84,984


$

68,657











Gross margin








Network Business









IMAX DMR(1)



$

18,782


$

17,467


Joint revenue sharing arrangements – contingent rent(1)




12,740



10,250


IMAX systems – contingent rent




-



688







31,522



28,405

Theater Business









IMAX systems










Sales and sales-type leases




11,609



3,220



Ongoing fees and finance income




2,683



2,521


Joint revenue sharing arrangements – fixed fees(1)




-



88


Theater system maintenance




6,205



4,249


Other theater




(45)



430







20,452



10,508

New Business




(1,469)



(337)











Other









Film distribution and post-production(1)




446



(2,663)


Other




(259)



(142)







187



(2,805)

Total



$

50,692


$

35,771

 

 

IMAX CORPORATION
OTHER INFORMATION
(in thousands of U.S. dollars)


Non-GAAP Financial Measures:


In this release, the Company presents adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share, EBITDA and adjusted EBITDA as supplemental measures of performance of the Company, which are not recognized under U.S. GAAP. The Company presents adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its stock-based compensation (net of any related tax impact) on net income. In addition, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share because it believes that they are important supplemental measures of its comparable financial results and could potentially distort the analysis of trends in business performance and it wants to ensure that its investors fully understand the impact of net income attributable to non-controlling interests and its stock-based compensation (net of any related tax impact) in determining net income attributable to common shareholders. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share should be considered in addition to, and not as a substitute for, net income and net income attributable to common shareholders and other measures of financial performance reported in accordance with U.S. GAAP.


The Company is required to maintain a minimum level of "EBITDA", as such term is defined in the Company's credit agreement (and which is referred to herein as "Adjusted EBITDA", as the credit agreement includes additional adjustments beyond interest, taxes, depreciation and amortization). EBITDA and Adjusted EBITDA (each as defined below) should not be construed as substitutes for net income or as better measures of liquidity as determined in accordance with U.S. GAAP.  The Company believes that EBITDA and Adjusted EBITDA are relevant and useful information widely used by analysts, investors and other interested parties in the Company's industry.




For the


For the




3 months ended


12 months ended



March 31, 2018


March 31, 2018

(1)

(In thousands of U.S. Dollars)







Net income

$

12,067


$

25,472


Add (subtract):








Provision for income taxes


4,453



21,129



Interest expense, net of interest income


247



935



Depreciation and amortization, including film asset amortization


13,380



67,668



EBITDA

$

30,147


$

115,204



Stock and other non-cash compensation


5,141



23,199



Write-downs, net of recoveries including asset impairments and








receivable provisions


1,036



21,041



Exit costs, restructuring charges and associated impairments


702



16,876



Loss from equity accounted investments


205



653



Adjusted EBITDA before non-controlling interests(2)

$

37,231


$

176,973



Adjusted EBITDA attributable to non-controlling interests


(5,824)



(25,906)



Adjusted EBITDA per Credit Facility

$

31,407

*

$

151,067

*


Adjusted EBITDA per Credit Facility, excluding impact from "Marvel's Inhumans"

$

31,463

*

$

139,047

*


Adjusted revenues attributable to common shareholders

$

75,958


$

353,698



Adjusted EBITDA margin, excluding impact from "Marvel's Inhumans"


41.3

%


42.7

%









Adjusted EBITDA per Credit Facility of $31.4 million and $151.1 million for the three and twelve months ended March 31, 2018 respectively, include the impact
of the Company's investment in "Marvel's Inhumans", which resulted in a $0.1 million and $13.0 million loss, respectively. However, as permitted by the Credit
Facility, this loss was offset by addbacks of $nil and $13.3 million for amortization and by addbacks of, $nil and $11.7 million for impairment charges relating to
the investment, in each case for the three and twelve months ended March 31, 2018, respectively. The net effect of these addbacks was to increase Adjusted
EBITDA per Credit Facility by $0.1 million and $12.0 million for the three and twelve months ended March 31, 2018, respectively. This investment represents the
Company's first foray into a commercial television property, and therefore the Adjusted EBITDA per Credit Facility metric presented above may not be reflective
of the Company's typical operational activity. Further, the Company does not yet know whether it will make similar investments in the future. As a result, the
Company is also presenting Adjusted EBITDA per Credit Facility excluding the impact of "Marvel's Inhumans" to better facilitate comparisons to prior and
future periods.



(1)

Ratio of funded debt calculated using twelve months ended Adjusted EBITDA.

(2)

The Adjusted EBITDA calculation specified for purpose of the minimum Adjusted EBITDA covenant excludes the reduction in Adjusted EBITDA from the
Company's non-controlling interests.

(3)



3 months ended March 31, 2018


12 months ended March 31, 2018


Total revenues




$

84,984




$

397,094


Greater China revenues


$

28,146




$

136,030




Non-controlling interest ownership percentage(4)


32.07%




31.90%




Deduction for non-controlling interest share of revenues





(9,026)





(43,396)


Adjusted revenues attributable to common shareholders




$

75,958




$

353,698













(4)

Weighted average ownership percentage for change in non-controlling interest share

 

 

IMAX CORPORATION
OTHER INFORMATION
(in thousands of U.S. dollars)


Adjusted Net Income and Adjusted Diluted Per Share Calculations – Quarter Ended March 31, 2018 vs. 2017:


The Company reported net income of $12.1 million, which calculates to $0.19 per basic and diluted share, for the first quarter of 2018 as compared to a net loss of $0.9 million, or $0.01 per basic and diluted share for the first quarter of 2017. Net income for the first quarter of 2018 includes a $4.8 million charge, or $0.08 per diluted share (2017 — $5.3 million or $0.08 per diluted share), for stock-based compensation and a $0.7 million charge, or $0.01 per diluted share (2017 - $nil), for exit costs, restructuring charges and associated impairments. Adjusted net income, which consists of net income excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments and the related tax impact, was $17.1 million, or $0.27 per diluted share, for the first quarter of 2018 as compared to adjusted net income of $3.0 million, or $0.05 per diluted share, for the first quarter of 2017. The Company reported net income attributable to common shareholders of $8.5 million, or $0.13 per basic and diluted share for the first quarter of 2018 (2017 — $0.1 million or $nil per basic and diluted share). Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments and the related tax impact, was $13.4 million, or $0.21 per diluted share, for the first quarter of 2018 as compared to adjusted net income attributable to common shareholders of $3.9 million, or $0.06 per diluted share, for the first quarter of 2017. A reconciliation of net income and net income attributable to common shareholders, the most directly comparable U.S. GAAP measure, to adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below:



Quarter Ended March 31,


(In thousands of U.S. dollars, except per share amounts)

2018



2017




Net Income


Diluted EPS



Net Income


Diluted EPS


Reported net income

$

12,067


$

0.19



$

(887)


$

(0.01)


Adjustments:















Stock-based compensation


4,847



0.08




5,264



0.08



Exit costs, restructuring charges and associated impairments


702



0.01




-



-



Tax impact on items listed above


(559)



(0.01)




(1,341)



(0.02)


Adjusted net income


17,057



0.27




3,036



0.05



Net (income) loss attributable to non-controlling interests


(3,562)



(0.06)




962



0.01


Stock-based compensation (net of tax of less than















$0.1 million and less than $0.1 million, respectively) 


(57)



-




(128)



-


Adjusted net income attributable to common shareholders

$

13,438


$

0.21



$

3,870


$

0.06

















Weighted average diluted shares outstanding





64,619







67,180





















 

 

Free Cash Flow:


Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company's after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below:









For the




Three months ended



March 31, 2018

(In thousands of U.S. Dollars)




Net cash provided by operating activities


$

15,463

Net cash used in investing activities



(11,953)


Net cash flow


$

3,510

 

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/imax-corporation-reports-first-quarter-2018-results-300639629.html

SOURCE IMAX Corporation